Eukaryotic cells target invading microbes to autophagosomes via a process termed xenophagy, which plays a key role in innate immune defense. Various intracellular bacterial pathogens, including *Mycobacterium tuberculosis*, are targeted for xenophagy via a ubiquitin-mediated pathway that surrounds bacteria with conjugated ubiquitin chains^[@R1]--[@R3]^. Marking with polyubiquitin presumably recruits ubiquitin-binding autophagy adaptors such as p62, which in turn engage the autophagic machinery for autophagosome formation and delivery of bacteria to the lysosome^[@R1],[@R3],[@R4]^. While ubiquitin binding adaptors are required for xenophagy, whether ubiquitin itself directly mediates bacterial autophagy is not clear as the identities of the ubiquitinated substrate(s) and ligase(s) responsible for coating cytosol-exposed bacteria are poorly understood.

In a fashion similar to xenophagy, the process of mitophagy eliminates damaged mitochondria through ubiquitin-mediated targeting to autophagosomes. A key step in mitophagy is marking of damaged mitochondria by the ubiquitin ligase PARKIN, which localizes to the organelle and directly ubiquitinates proteins on its surface^[@R5]^. Ubiquitin-tagged mitochondria are directed to the autophagosome pathway via p62^[@R6]--[@R8]^ and several other factors^[@R10]^, ultimately delivering the organelle to the lysosome^[@R5]^.

*Park2* mutations in humans are well-known risk factors for the development of Parkinson's disease, but polymorphisms in the regulatory region of *Park2,* some of which result in decreased PARKIN expression^[@R9]^, have been associated with increased susceptibility to the intracellular pathogens *Mycobacterium leprae* and *Salmonella typhi*^[@R10],[@R11]^. Although a genetic link to increased infection risk has been identified, the function of PARKIN in immunity remains obscure. We have identified that PARKIN, similar to its role in mitophagy, is also important for innate defense against *M. tuberculosis* and other intracellular pathogens by promoting xenophagy. This work provides a possible mechanism underlying the human genetic studies linking PARKIN to increased susceptibility to bacterial infection and reveals a surprising connection between mitochondrial homeostasis and pathogen defense.

PARKIN in TB-ubiquitin colocalization {#S1}
=====================================

We have shown previously that upon infection of macrophages, *M. tuberculosis* bacilli that puncture phagosomal membranes via their ESX-1 secretion system gain access to the host cytosol but become enveloped by conjugated ubiquitin chains and are targeted to autophagosomes via p62 and NDP52^[@R3]^. Although the role of ESX-1 in autophagy induction is likely complicated^[@R12]^, it is clear that approximately one-third of wild-type intracellular bacteria are targeted to autophagy during macrophage infection and that this plays a major role in host resistance to infection^[@R2],[@R3]^. Because of the commonalities between mitophagy and autophagy of intracellular mycobacteria, and the links between *Park2* polymorphisms and increased susceptibility to bacterial infection in humans, we hypothesized that PARKIN may also be recruited to *M. tuberculosis*-containing phagosomes and target them for ubiquitin-mediated autophagy. Indeed, after infection of murine bone marrow-derived macrophages (BMDMs) with *M. tuberculosis* expressing mCherry, we found that PARKIN localized to approximately 12% of wild-type *M. tuberculosis* phagosomes but not to ESX-1 mutants ([Fig. 1a](#F1){ref-type="fig"}, [Extended Data Fig. 1](#SD1){ref-type="supplementary-material"}). Next, we infected BMDMs isolated from wild-type and *Park2^−/−^* mice and performed immunofluorescence co-localization experiments using antibodies that recognize polyubiquitin. As shown in [Fig. 1b--c](#F1){ref-type="fig"}, *Park2^−/−^* BMDMs were severely defective for *M. tuberculosis* ubiquitin colocalization as compared to control macrophages, resulting in a significant reduction in ubiquitin-positive mycobacteria. Likewise, shRNA knock-down of PARKIN expression in human macrophage cell lines also resulted in a drastic reduction in ubiquitin localization with *M. tuberculosis* cells ([Fig. 1d--f](#F1){ref-type="fig"}), indicating that PARKIN plays a conserved role in mycobacterium ubiquitination in mice and humans. Knock-down of LRSAM1, a ubiquitin ligase recently implicated in antibacterial defense and ubiquitination of Salmonella^[@R1],[@R3],[@R4],[@R13]^, had no effect on ubiquitin or GFP-LC3 colocalization with *M. tuberculosis* ([Extended Data Fig. 1b, c](#SD1){ref-type="supplementary-material"}). Expression of wild-type *Park2* in *Park2^−/−^* cells restored ubiquitin localization around *M. tuberculosis* cells ([Fig. 1g, h](#F1){ref-type="fig"}). In contrast, *Park2^−/−^* BMDMs expressing either of two pathogenic RING domain mutant alleles that inactivate PARKIN's E3 ligase activity, T240R or P437L^[@R3],[@R4],[@R14]--[@R16]^, failed to restore ubiquitin colocalization with *M. tuberculosis* ([Fig. 1g, h](#F1){ref-type="fig"}). Taken together, these data demonstrate that Parkin and its E3 ligase activity are critical for the colocalization of ubiquitin with *M. tuberculosis* during infection.

PARKIN mediates K63-linked polyubiquitin {#S2}
========================================

We showed previously that both K63- and K48-linked polyubiquitin chains accumulate around *M. tuberculosis*^[@R3]^. Because PARKIN is known to catalyze K63-linked ubiquitin chains^[@R5],[@R17]^, we sought to determine the nature of the residual ubiquitin surrounding *M. tuberculosis* in *Park2^−/−^* BMDMs. Using ubiquitin linkage-specific antibodies^[@R5],[@R18]^, we found that in wild-type BMDMs, approximately 26--29% of all intracellular bacteria (\~90--95% of all ubiquitin-positive bacilli) co-localized with K63 ubiquitin, whereas only 5--7% bacilli stained for K48 ([Fig. 2a--b](#F2){ref-type="fig"}). Additionally, expression of HA-epitope-tagged forms of K48 and K63 ubiquitin within BMDMs supported the notion that K63-linked polyubiquitin is more abundant surrounding *M. tuberculosis* than the K48-linked form ([Extended Data Fig. 2](#SD2){ref-type="supplementary-material"}). In *Park2^−/−^* BMDMs, however, there was a specific decrease in the number of K63-positive mycobacteria, while the K48-positive population remained unaffected ([Fig. 2a--b](#F2){ref-type="fig"}, [Extended Data Fig. 2](#SD2){ref-type="supplementary-material"}). Previous electron microscopy studies indicated that though ubiquitin can localize directly with *M. tuberculosis*, the majority of ubiquitin is found on membranous structures surrounding *M. tuberculosis*-containing phagosomes^[@R15],[@R19]--[@R21]^. To address whether bacterial or host proteins become ubiquitinated, we used a digitonin-based method that specifically permeabilizes the plasma membrane and leaves phagosomes intact with luminal contents inaccessible to antibodies^[@R10],[@R22]^ ([Extended Data Fig. 3a](#SD3){ref-type="supplementary-material"}). As shown in [Extended Data Fig. 3b](#SD3){ref-type="supplementary-material"}, antibodies against poly-ubiquitin and K63-ubiquitin stained digitonin-permeabilized cells and resulted in colocalization with mCherry-expressing *M. tuberculosis*. Importantly, anti- *M. tuberculosis* antibodies failed to stain *M. tuberculosis* within digitonin-permeabilized cells and only stained cells after addition of Triton-X100 detergent, demonstrating that digitonin permeabilized cells contained intact phagosomes ([Extended Data Fig. 3b, c](#SD3){ref-type="supplementary-material"}). Taken together, these data suggest that PARKIN facilitates the linkage of K63-linked ubiquitin chains surrounding *M. tuberculosis* containing phagosomes, although the exact protein target(s) remain to be explored. Furthermore, this data also suggests at least one other ubiquitin ligase works independently of PARKIN to catalyze the K48-linked ubiquitination that surrounds a minor population of *M. tuberculosis* cells.

PARKIN required for TB autophagy {#S3}
================================

Ubiquitination coincides with autophagic targeting of *M. tuberculosis*, but a causal relationship has not been demonstrated. To determine whether Parkin-mediated ubiquitination directs autophagic targeting of *M. tuberculosis*, we infected wild-type and *Park2^−/−^* macrophages with *M. tuberculosis* and measured colocalization of bacilli with multiple markers of autophagy. Microscopy analysis of proteins involved in ubiquitin recognition (NBR1, NDP52, p62, phospho-TBK1) revealed reduced colocalization with *M. tuberculosis* in *Park2^−/−^* macrophages ([Fig. 2c--d](#F2){ref-type="fig"}), suggesting that PARKIN-mediated ubiquitination directly leads to the recruitment of the proximal ubiquitin-adaptors that facilitate autophagic targeting of mycobacteria. Likewise, mycobacterial cells within infected *Park2^−/−^* BMDMs had reduced colocalization with autophagic proteins LC3 and ATG12 relative to infection of wild-type BMDMs ([Fig. 3a--b](#F3){ref-type="fig"}), suggesting that the K63-linked polyubiquitin catalyzed by PARKIN is required for delivery of *M. tuberculosis* to autophagosomes. Consistent with this notion, *Park2^−/−^* cells were defective in conversion of LC3 to its activated, lipidated form, LC3-II, during *M. tuberculosis* infection, further demonstrating that Parkin is required for autophagy of mycobacteria ([Fig. 3c](#F3){ref-type="fig"}).

PARKIN limits TB replication {#S4}
============================

The autophagy pathway serves to limit *M. tuberculosis* replication in macrophages by delivering bacilli to the lysosome^[@R3],[@R11]^. To determine if PARKIN mediated ubiquitination is required for autophagic targeting of *M. tuberculosis* to lysosomes, we infected BMDMs with *M. tuberculosis* and monitored co-localization with the lysosomal marker, LAMP1. During *M. tuberculosis* infection of wild-type BMDMs, approximately 30% of bacilli stained positive for LAMP1 at 6 hrs post-infection ([Fig. 3d--e](#F3){ref-type="fig"}). In contrast, only 2--5% of bacilli colocalized with LAMP1 during *M. tuberculosis* infection of *Park2^−/−^* macrophages. This was similar to macrophages deficient for the essential autophagy protein, ATG5 ([Fig. 3d--e](#F3){ref-type="fig"})^[@R3],[@R5]^. To test whether these differences led to changes in bacterial survival, we infected *Park2*^−/−^ and *Atg5*^−/−^ BMDMs with wild-type *M. tuberculosis* and determined bacterial viability by enumerating colony-forming units (CFUs). Infection of BMDMs deficient for either ATG5 or PARKIN resulted in a 2- and 2.5-fold increase in bacterial numbers, respectively, relative to control BMDMs by 12 hours post-infection ([Fig. 3f](#F3){ref-type="fig"}). Conversely, overexpression of PARKIN in RAW 264.7 macrophages led to decreased bacterial replication ([Fig. 3g](#F3){ref-type="fig"}). Importantly, knock-down of PARKIN expression in human U937 cells also led to an increase in bacterial replication during infection ([Fig. 3h](#F3){ref-type="fig"}). Taken together, our data demonstrates that PARKIN-mediated ubiquitination leads to the autophagic targeting of *M. tuberculosis* and is essential for inhibition of mycobacterial replication in macrophages.

PARKIN mediates *M. tuberculosis* immunity {#S5}
==========================================

Polymorphisms within the regulatory region of *Park2* in human populations have been identified as a common risk factor for increased susceptibility to *Mycobacterium leprae* and salmonella infection^[@R6],[@R7],[@R10],[@R11]^, suggesting that PARKIN plays an important role *in vivo* against a broad range of intracellular bacterial infections. We began to test this by first determining whether PARKIN was required *in vivo* during *M. tuberculosis* infection of mice. We performed a low-dose aerosol infection of wild-type and *Park2*^−/−^ knockout mice and determined mouse survival and bacterial burden within infected tissues. In comparison to infected wild-type mice, *Park2*^−/−^ knockout mice had a 10-fold increase in bacterial CFUs within infected lungs, spleens and liver by 21 days post-infection ([Fig. 4a, b](#F4){ref-type="fig"}). Furthermore, survival studies revealed that *Park2*^−/−^ mice were extremely susceptible to *M. tuberculosis* as all infected mice succumbed to overwhelming infection by 85 days post-infection, while all infected wild-type mice remained alive and displayed no-overt signs of weight-loss or stress ([Fig. 4c](#F4){ref-type="fig"}). Immunohistochemistry staining of infected mouse lungs revealed robust PARKIN expression in mouse granulomas within the central macrophage containing zone ([Fig. 4d](#F4){ref-type="fig"}). In agreement with our mouse experiments, we also observed high expression of PARKIN within human lung granuloma tissue samples from *M. tuberculosis* infected patients ([Fig. 4e](#F4){ref-type="fig"}, [Extended Data Fig. 4](#SD4){ref-type="supplementary-material"}). Further analysis of human lung specimens via confocal microscopy revealed the presence of PARKIN puncta within *M. tuberculosis* infected cells as well as *in vivo* colocalization of PARKIN with *M. tuberculosis* ([Fig. 4f](#F4){ref-type="fig"}). Lastly, *Park2*^−/−^ mice were also highly susceptible to another intracellular pathogen, *L. monocytogenes*, resulting in 10--20 fold higher bacterial burdens relative to wild-type mice within infected spleens and liver ([Fig. 4g](#F4){ref-type="fig"}). Taken together, this data demonstrates that PARKIN is essential *in vivo* for controlling intracellular bacterial pathogens within mice and suggests an *in vivo* role for Parkin in human tuberculosis disease.

Conserved role of PARKIN in immunity {#S6}
====================================

*Park2* is present in all metazoans^[@R8],[@R23]^, including *Drosophila melanogaster* and *Caenorhabditis elegans*, with well-characterized functions in mitochondrial maintenance and in models of Parkinson's disease. Because xenophagy of intracellular pathogens is a highly evolutionarily conserved innate immune defense mechanism^[@R24]^, we sought to determine whether Parkin also plays an evolutionarily conserved role in immunity within non-mammalian organisms. We began by first analyzing PARKIN-deficient *D. melanogaster* strains using models of bacterial systemic infection. We obtained two mutant fly lines with independent disruptions of the *Parkin* gene (*Park^f^*^01950^, *Park*^c00062^) and infected them with *L. monocytogenes,* which has previously shown to induce autophagy within flies^[@R25],[@R26]^. In contrast to wild-type infected flies, *Parkin* mutants were severely defective in ATG8/LC3 processing during infection ([Fig. 5a](#F5){ref-type="fig"}), suggesting that *Parkin* plays a role in autophagic immunity within flies. Consistent with our results in mice, *Parkin* mutant flies were also highly susceptible to *L. monocytogenes* infection and led to 10--50 fold increases in bacterial burdens relative to wild-type infected flies ([Fig. 5b](#F5){ref-type="fig"}). This was accompanied with decreased survival, with a median lifespan of two days following infection ([Fig. 5c](#F5){ref-type="fig"}). In addition, *Parkin* mutant flies were also susceptible to other autophagy inducing intracellular pathogens such as *S*. Typhimurium and *Mycobacterium marinum*. By 9 hours post infection, Parkin deficient flies had a 10-fold increase in *S*. Typhimurium burden relative to wild-type flies ([Fig. 5d](#F5){ref-type="fig"}). Moreover, PARKIN mutant flies had significantly decreased life spans upon infection with either *S*. Typhimurium ([Fig. 5e](#F5){ref-type="fig"}) or *M. marinum* ([Fig. 5f](#F5){ref-type="fig"}). Lastly, *C. elegans* strains deficient in the *Parkin* homolog (*PDR-1*) were also highly susceptible to *S*. Typhimurium infection (data not shown). All together, our data shows that *Parkin* homologs within lower metazoans are required for proper immune response to infection, suggesting an evolutionarily conserved role in innate immunity.

Discussion {#S7}
==========

Our findings reveal that PARKIN regulates a common cellular program by which metazoans mediate quality control of endogenous mitochondria (self) and eradicate harmful bacterial pathogens (non-self). Although these two activities are seemingly disparate, the evolutionary origin of mitochondria from a bacterial endosymbiont suggests that perhaps mitochondrial dysfunction triggers the recognition of the organelle as non-self. For example, mitochondria (and bacterial endosymbionts^[@R5],[@R27]^) may actively evade PARKIN surveillance, but these inhibitory processes are overridden upon organelle damage. Alternatively, several studies have shown that damaged mitochondria may serve as a "danger-associated molecular pattern", resulting in the activation of several innate immune receptors such as toll-like receptors and the NLRP3-inflammasome complex^[@R28],[@R29]^. In view of recent studies showing that intracellular infection with several pathogens such as *L. monocytogenes* result in altered host mitochondria dynamics^[@R30]^, it is tempting to speculate that damaged mitochondria may serve as a signal for intracellular infection and activation of xenophagy.

Our results also provide a molecular explanation for increased bacterial susceptibility of humans with polymorphisms in the *Park2* regulatory region^[@R3],[@R10],[@R11]^, broadening the role of PARKIN beyond mitochondrial homeostasis. Indeed, several recent studies have shown PARKIN to participate in a wide array of cellular processes such as apoptosis^[@R31]^, regulation of lipid metabolism^[@R32]^, and cytokine production upon infection^[@R33]^, all of which may contribute to the *in vivo* importance of PARKIN in immunity. Lastly, this work highlights the unexpected connection between mitochondrial-based neuronal disorders and susceptibility to bacterial infection in humans. Recent genome wide association studies on inflammatory bowel disease, which is linked to altered host-gut microbe interactions, have identified susceptibility SNPs within *LRRK2* and *Park7*, two genes canonically associated with Parkinson's disease^[@R34],[@R35]^. Thus, we surmise that genes typically associated with neuronal maintenance or mitophagy may play broad roles in cellular homeostasis within various cell types.

Full Methods {#S9}
============

Mice and macrophages {#S10}
--------------------

*Park2^−/−^* mice on the C57L/B6 background were a gift from K. Nakamura (Gladstone Institute)^[@R12],[@R36]^. GFP-LC3 transgenic mice on the C57L/B6 were a gift from N. Mizushima and used were as previously described^[@R3]^. *Wild-type C57BL/6 mice were purchased from Jackson laboratories.* BMDMs were obtained from mouse femurs as previously described^[@R3]^ and cultured in DMEM H-21 supplemented with 20% FBS and *10% MCSF derived from 3T3-MCSF cells.* U937 and Raw264.7 cells were obtained from ATCC and tested for mycoplasma prior to purchase. U937 monocytes were stimulated overnight with 20ng/ml of PMA (Sigma) prior to infections.

Antibodies {#S11}
----------

The following antibodies were used: LC3B (L10382 Invitrogen), NDP52 (Abnova D01), p62/SQSTM1 (Abnova 2C11), rabbit anti-drosophila ATG-8 (Gift from S. Cherry, U Penn), anti-Mtb (BEI Resources NR-13818), poly-ubiquitin (Enzo FK1), phospho-TBK1 (Cell Signaling \#5483), Tubulin (Cell Signaling \#2128), mouse-monoclonal Parkin (Cell Signaling \#4211) and ATG12 (Cell Signaling \#2011), rabbit polyclonal anti-Parkin (Abcam 15954), anti-NBR1 (Abcam 55474), humanized rabbit monoloncal antibodies specific for K63 or K48 (Gift from E. Brown lab at Genentech).

Bacterial strains {#S12}
-----------------

The following bacterial strains were used: *M. tuberculosis* (Erdman), *L. monocytogenes* (10403s), *M. marinum* (M), and *S*. Typhimurium (SL1344). Wild-type and Δ*esxA* mycobacteria expressing mCherry was previously described^[@R3]^.

Macrophage infection {#S13}
--------------------

For infections with *M. tuberculosis*, macrophages were infected as previously described^[@R3]^. Briefly, *M. tuberculosis* cultures were washed twice with PBS, gently sonicated to disperse clumps, and resuspended in DMEM supplemented with 10% horse serum. Media was removed from cells, monolayers overlaid with the bacterial suspension, and centrifuged for 10 min at 1,000 RPM. Cells were washed twice in PBS and returned to macrophage media. For determination of bacterial viability following infection, cells were lysed in 1% Triton-X 100 and plated on 7H10 solid media.

Western blotting {#S14}
----------------

Protein lysates from cells and flies were obtained by lysis in RIPA buffer (Sigma) at the indicated time points. Micro BCA protein kit (Pierce) was used to measure protein levels and equal amounts of protein were electrophoresed on 4--20% Tris-HCL Criterion gels (Biorad), and transferred onto nitrocellulose membranes. Western blots were analyzed using an Odyssey Imager (Licor) according to manufacturer's instructions. Western blot figures are a representative of at least two independent experiments.

Immunofluorescence {#S15}
------------------

Infected cells were immunostained and visualized as previously described^[@R3]^. Briefly, macrophages were seeded onto poly-lysine coated coverslips and infected with *M. tuberculosis* as described above. Cells were infected at an MOI of 1, and fixed in 4%PFA for 20 min at the indicated time points. Cells were incubated with indicated primary antibodies for 2 h at room temperature in 5% milk, 0.05% saponin and visualized using secondary Alexa-fluor488 antibodies. For Parkin immunofluorescence, cells were stained using rabbit polyclonal anti-Parkin (Abcam15954) and an HRP conjugated donkey anti-rabbit secondary (1:100, Jackson Immunochemicals) followed by amplification with alexafluor-488 tyramide (Invitrogen). Colocalization studies were performed as blinded experiments, with a minimum count of 200 cells per coverslip and performed in triplicate. Data shown is the mean ± SEM of at least 3 experiments.

Mouse infection {#S16}
---------------

Non-randomized mice (female 5--8 weeks old) were infected with *M. tuberculosis* via low-dose aerosol infection (200 CFU) as previously described^[@R37]^. Sample size (N=5 per group) was based on empirical evidence from previously published reports^[@R37]^ as the size necessary for adequate statistical analysis. Lungs, liver and spleens were harvested, homogenized, and plated on 7H10 agar plates. For survival experiments, infected mice were euthanized when they had lost 15% of their maximal body weight. For *L. monocytogenes* infections, mice were infected via intraperitoneal injection with 4 × 10^5^ bacteria. 96 hours post infection, liver and spleen from infected mice were homogenized and serial dilutions were plated onto BHI agar plates. No blinding was done for these animal studies and all mice were housed and treated humanely using procedures described in an animal care protocol approved by University of California, San Francisco, Institutional Animal Care and Use Committee.

Fly strains and infections {#S17}
--------------------------

The white1118 strain (Bloomington stock center, stock 6326) was used as the wild-type parental strain for all experiments. The *Park*^c00062^ and *Park^f^*^01950^ alleles are from the Exelexis piggyBac transposon collection^[@R38]^. *Park*^c00062^ was obtained from Bloomington stock center and *Park^f^*^01950^ was obtained from the Exelexis collection at Harvard. Infections were done as previously described^[@R39]^. Male 5 to 7 day-old files were anesthetized with CO2 and injected *L. monocytogenes* (1000 CFU), *S*. Typhimurium (2500 CFU), or *M. marinum* (1000 CFU) in 50 nl of culture into the anterior abdomen. Infected flies were homogenized in PBS supplemented with 1% Triton X-100 and serial dilutions were plated onto solid media. For survival analysis, the number of dead flies was counted daily and analyzed via log-rank test.

Lentiviral virus knockdown and complementation {#S18}
----------------------------------------------

Lentivirus expressing shRNAs targeting *Park2* and *LRSAM1* transcripts were generated using the Mission PLKO.1 lentivirus system from Sigma. A lentivirus expressing a non-targeting scrambled shRNA was used as a control. U937 cells were transduced with lentivirus per manufacturer's instructions and stable cell lines were generated via selection with puromycin. For transgene expression of *Park2* and *Park2* mutants, full length *Park2* was cloned into pBluescript vector and RING domain mutants were generated using Quick-Change site directed mutagenesis kit (Stratagene). HA-tagged ubiquitin constructs were obtained from Addgene^[@R31]^. Lentivirus expressing protein constructs were generated using the pLentiX system^[@R3]^. RAW264.7 cells were transduced and selected on puromycin for 1 week. BMDM cells expressing lentiviral constructs were generated by transducing marrow cells from knockout mice with lentivirus followed by differentiation into macrophages as described above. During day 3 of differentiation, cells were selected with 5ug/ml of puromycin.

Statistics {#S19}
----------

Statistical analysis of data was performed using GraphPad Prism software (Graphpad; San Diego, CA). Two-tailed unpaired Student's t tests were used for analysis of microscopy images and mycobacterium CFU assays. The Kaplan-Meir method was used to analyze mouse survival.

RNA isolation and qPCR {#S20}
----------------------

RNA was isolated and purified from cells using the Trizol micro-midi RNA isolation kit (Invitrogen) per manufacturer's instructions. For qPCR analysis 2μg of RNA was reverse transcribed using the VILO cDNA synthesis kit (Invitrogen) and qPCR analysis was performed in triplicate using a MJ Research Opticon 3200 machine. Data graphed in figures are representative of at least three independent experiments.

Digitonin permeabilization {#S21}
--------------------------

Differential digitonin permeabilization of infected macrophages was performed as previously described.^[@R30]^

Immunohistochemistry of mouse specimens {#S22}
---------------------------------------

Paraffin embedded specimens were deparaffinized in xylene, subjected to heat mediated antigen-retrieval in 10mM sodium citrate (pH 6.0), permeabilized in 0.2% Triton-100 (Sigma), treated with mouse on mouse blocking reagent (Vector Laboratories), and blocked in 5% donkey sera. Parkin was detected using a mouse monoclonal anti-Parkin antibody (Cell signal \#4211) (1:50) and an HRP-conjugated donkey anti-rabbit secondary (1:250, Jackson immunochemicals), amplified with AB reagent (Vectastain) and detected using DAB reagent (Thermo Scientific). Images were acquired using a Zeiss Axioplan 2 microscope.

Immunohistochemistry and immunofluorescence of human specimens {#S23}
--------------------------------------------------------------

Human lung biopsy specimens were obtained from patients with active tuberculosis. Paraffin embedded specimens were deparaffinized in xylene, subjected to heat mediated antigen-retrieval in 10mM sodium citrate (pH 6.0), permeabilized in 0.2% Triton-100 (Sigma) and blocked in 5% donkey sera. For immunohistochemistry, Parkin was detected using a rabbit polyclonal anti-Parkin antibody (abcam) (1:25) and an HRP-conjugated donkey anti-rabbit secondary (1:250, Jackson immunochemicals), amplified with AB reagent (Vectastain) and detected using DAB reagent (Thermo Scientific). Images were acquired using a Zeiss Axioplan 2 microscope. For immunofluorescence, Parkin was identified using rabbit polyclonal anti-Parkin (Abcam15954) at 1:25 and an HRP conjugated donkey anti-rabbit secondary (1:100, Jackson Immunochemicals) followed by amplification with tyramide (1:50, Perkin Elmer). TB was identified using guinea pig anti-TB (1:25,) and an Alexa 488 conjugated donkey anti-guinea pig secondary (1:100, Jackson Immunochemicals). Images were acquired using a Leica TCS SP5 confocal microscope. All human tissue specimens were obtained with consent. This study of human tissue specimens has been exempted under 45 CFR 46.101(b) and was approved by the Institutional Review Board at the University of Texas Southwestern Medical Center.

Supplementary Material {#S24}
======================

###### Extended Data Figure 1. Quantification of PARKIN colocalization and effect of LRSAM1 knockdown in BMDMs

**a,** Quantification of PARKIN-positive *M. tuberculosis* in BMDMs from wild-type and *Park2^−/−^* mice, from [Figure 1a](#F1){ref-type="fig"}. **b,** BMDMs from LC3-GFP transgenic mice were transduced with lentivirus expressing either a scrambled shRNA control (Ctrl) or shRNAs targeting either LRSAM1 or PARKIN. Lentiviral transduced cells were than infected with mCherry-expressing *M. tuberculosis* and the colocalization of GFP-LC3 and ubiquitin was quantified via immunofluorescence. \*P\<0.014, \*\*P\<0.008 by Student's t-test **b**, RT-qPCR expression of LRSAM1 and PARKIN transcripts in lentiviral transduced cells from (a). Data shown is expressed relative to actin expression. \*P\<0.033, \*\*P\<0.0035 by Student's t-test.

###### Extended Data Figure 2. Colocalization of HA-ubiquitin species during M. tuberculosis infection

**a**, Wild-type BMDMs were transduced with lentivirus expressing HA-tagged constructs of wild-type ubiquitin (WT), ubiquitin with all lysine residues mutated to arginine except for lysine 63 (K63), or ubiquitin with all lysine residues mutated to arginine except for lysine 48 (K48). Transduced cells were then infected with mCherry-expressing *M. tuberculosis* and immunostained using anti-HA antibodies 4 hours post-infection. **b**, Quantification of HA-ubiquitin colocalization with *M. tuberculosis* from (a). \*\*P\<0.001 by Student's t-test.

###### Extended Data Figure 3. Digitonin permeabilization of BMDMs

**a,** Cartoon model explaining digitonin differential permeabilization of macrophages and antibody accessibility to phagosomes. **b,** Microscopy images of Wild-type BMDMs were infected with mCherry expressing *M. tuberculosis*. Cells were immunostained via digitonin permeabilization alone or digitonin permeabilization with triton X-100 treatment. **c,** Quantification of ubiquitin colocalization with *M. tuberculosis* from (b). N.D., not determined.

###### Extended Data Figure 4. Immunohistochemistry analysis PARKIN within human patients with active tuberculosis

Lung biopsy samples were obtained from three different human patients with active tuberculosis. Immunohistochemistry was performed on specimens using either anti-PARKIN, anti-*M. tuberculosis* or an IgG control antibody. Positive cells were visualized via DAB staining. Scale bar = 1003m.
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![PARKIN activity is required for *M. tuberculosis*-ubiquitin colocalization\
**a,** Wild-type (WT) and *Park2*^−/−^ BMDMs were infected with mCherry-expressing *M. tuberculosis* for 4 h and immunostained using anti-PARKIN antibodies. **b,** Wild-type BMDMs were infected with mCherry-*M. tuberculosis* for 4 h and immunostained for polyubiquitin. **c,** Quantification of ubiquitin-positive *M. tuberculosis* from (**b**). Results are means ± SEM of three independent experiments (\*\*P\<0.001, paired Student's t-test). **d,** U937 human macrophages expressing a scrambled shRNA (Control) or one of two different shRNAs targeting *Park2* (shRNA\#1, shRNA\#2) were infected with mCherry-*M. tuberculosis* for 12 h and immunostained for polyubiquitin. **e,** Quantification of ubiquitin positive *M. tuberculosis* from (**d**)**,** results are means ± SEM of three independent experiments (\*\*P\<0.005, Student's t-test). **f,** PARKIN and actin expression in cells from (**e**) was determined by western blotting. **g,** *Park2*^−/−^ BMDMs were transduced with lentivirus expressing BFP (−), wild-type PARKIN, or two separate mutant PARKIN alleles (T240R, P437L). Cells were infected with *M. tuberculosis* for 4 h and ubiquitin-*M. tuberculosis* colocalization was quantified and expressed relative to control BMDMs. Results are means ± SEM of three independent experiments (\*\*P\<0.005, paired Student's t-test). **h,** PARKIN and actin expression in cells from (**g**) was determined by western blotting.](nihms516387f1){#F1}

![PARKIN mediates K63-ubiquitin colocalization of *M. tuberculosis* and recruitment of ubiquitin-autophagy receptors\
**a,** BMDMs were infected with mCherry-*M. tuberculosis* for 4 h and immunostained using linkage-specific ubiquitin antibodies. **b,** Quantification of K63 and K48 ubiquitin positive *M. tuberculosis* from (**a**). (\*\*P\<0.001, paired Student's t-test). **c,** Same as (**a**) except immunostained for NDP52, p62, phospho-TBK1, or NBR1. **d,** Quantification of colocalization from (**c**)**,** (N=3 per group, \*\*P \< 0.001).](nihms516387f2){#F2}

![PARKIN mediates autophagic targeting of *M. tuberculosis* and limits replication\
**a,** BMDMs were infected with mCherry-*M. tuberculosis* for 4 h and immunostained for LC3 or ATG12. **b,** Quantification of results from (**a**) (N=3 per group, \*\*P \< 0.001). **c,** Western blot analysis of LC3b from cell lysates from (**a**)**. d,** BMDMs were infected with mCherry-*M. tuberculosis* for 6 h and immunostained for Lamp1. **e,** Quantification of results from (**d**) expressed relative to control BMDMs (N=3 per group, \*\*P \< 0.001). **f,** BMDMs were infected with *M. tuberculosis* and colony forming units (CFU) at t=0 and t=16 h were determined by plating. Results were normalized to t=0 (N=3 per group, \*P \< 0.02). **g,** 33 RAW264.7 macrophages transduced with lentivirus expressing GFP or PARKIN were infected with *M. tuberculosis* and CFU were determined after 16 h, results were normalized to GFP-expressing cells (N=3 per group, \*\*P \< 0.0076). **h,** U937 human macrophages expressing either scrambled or *Park2* shRNAs were infected with *M. tuberculosis* for 36 h and CFU were determined. Results were normalized to t=0 (N=3 per group, \*P \< 0.02).](nihms516387f3){#F3}

![PARKIN is required for control of bacterial infection *in vivo*\
**a,** WT and *Park2*^−/−^mice were infected with wild-type *M. tuberculosis* via aerosol and lung bacterial burdens were determined by plating (means ± SD, N=5 per group, \*P\<0.02 by Student's t-test). **b,** Enumeration of liver and spleen CFU from mice infected in (**a**) 21 days post-infection. (means ± SD, N=5 per group, \*P\<0.03 by Student's t-test). **c,** Survival of *M. tuberculosis*-infected WT and *Park2*^−/−^ mice (N=10, \*\*P\<0.001 by log-rank test). **d,** Immunohistochemistry staining of lung sections from infected mice 21 days post-infection, scale bar = 100μm. **e,** Immunohistochemistry staining of lung sections from a human patient with active tuberculosis. **f,** Confocal microscopy images of human lung sections from (**e**) immunostained for *M. tuberculosis* and PARKIN; DNA was visualized using DAPI. **g,** Mice were infected with WT *L. monocytogenes* via IP injection and bacterial burdens in livers and spleens were determined by plating (means ± SD, N=7 per group, \*P\<0.04 by Student's t-test).](nihms516387f4){#F4}

![PARKIN is required for control of *S*. Typhimurium and *M. marinum* infection within flies\
**a**, WT and two independent *Parkin*-deficient *D. melanogaster* lines (*Park*^c00062^, *Park^f^*^01950^) were infected with *L. monocytogenes* via anterior abdomen injection. ATG8 processing was monitored in whole-fly protein lysates by western blotting. **b,** *L. monocytogenes* CFU from (**a**) were determined by plating (means ± SD, N=3--5, \*\*P\<0.001 by Student's t-test) and **c**, survival of *D. melanogaster* was determined (N=33, \*\*P\<0.001 by log-rank test). **d, e,** Flies were infected with *S*. Typhimurium and **d,** bacterial CFU (means ± SD, N=3--5 per group, \*\*P\<0.009 by Student's t-test) and **e,** fly survival were determined (N=59, \*\*P\<0.001 by log-rank test). **f**, Survival of flies infected with *M. marinum* (N=37, \*\*P\<0.0045 by log-rank test).](nihms516387f5){#F5}
